Biolab
- Company typePrivate
- Founded1980
- HeadquartersMuang Samut Prakan, Thailand
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Biolab firmographics
Firmographics- Name
- Biolab
- Legal name
- Biolab Co., Ltd.
- Website
- https://biolab.co.th
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Biolab industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
Keywords
Where Biolab is headquartered
LocationHeadquarters
- HQ city
- Muang Samut Prakan
- HQ country
- Thailand
- HQ region
- Asia
Offices1 record
Markets served
Biolab business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Manufacturing (OEM/ODM): Contract manufacturing of pharmaceutical products for domestic and international clients under OEM/ODM arrangements
- Own Brand Pharmaceuticals: Manufacturing and sale of proprietary pharmaceutical products under Biolab brand covering multiple therapeutic categories
- Product Registration Consulting: Consulting and execution services for product registration and regulatory compliance
- Laboratory Testing Services: Laboratory testing services for quality and safety assurance of pharmaceutical products
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Biolab product offering
Product offeringCore offering
Biolab Co., Ltd. manufactures generic pharmaceutical products, dietary supplements (Pharmafood), and cosmeceuticals, and provides OEM/ODM contract manufacturing, R&D of new formulations, product registration consulting, and laboratory testing services. The company produces over 100 products across 13 therapeutic categories (Gastrointestinal, Musculo-Skeletal, Endocrine & Metabolic, Dermatologicals, CNS, Allergy & Immune, Anti-Infectives, Respiratory, Contraceptives, Cardiovascular, Hormones, Calcium & Mineral, and Detoxifying Agents) and exports to 20+ countries.
Product overview
Biolab is a Thai pharmaceutical manufacturing company with over 45 years of experience, operating as a single integrated product and service portfolio. The company produces quality pharmaceuticals across 13 therapeutic categories (Gastrointestinal, Musculo-Skeletal, Endocrine & Metabolic, Dermatologicals, CNS, Allergy & Immune, Anti-Infectives, Respiratory, Contraceptives, Cardiovascular, Hormones, Calcium & Mineral, and Detoxifying Agents), dietary supplements branded as Pharmafood, and cosmeceutical skincare products. Complementary to product manufacturing, Biolab offers comprehensive services including R&D for new formulations, OEM/ODM manufacturing, product registration consulting, and laboratory testing services. All operations are certified to international standards including PIC/S GMP, EU GMP, and ISO/IEC 17025.
Differentiator
Problem solved
Functional benefit
Brands
- Pharmafood: Nutraceutical and dietary supplement product line for health and beauty care
Products and services
- Pharmaceuticals (ยาแผนปัจจุบัน) Quality pharmaceutical products for disease treatment covering all therapeutic categories: Gastrointestinal, Musculo-Skeletal, Endocrine & Metabolic, Dermatologicals, CNS, Allergy & Immune, Anti-Infectives, Respiratory, Contraceptives, Cardiovascular, Hormones, Calcium & Mineral, and Detoxifying Agents. Sold under the Biolab brand to pharmaceutical distributors and healthcare providers.
- Pharmafood (ผลิตภัณฑ์เสริมอาหาร) Dietary supplement products under the Pharmafood sub-brand providing nutritional support and holistic health and beauty care benefits. Marketed to consumers and distributors seeking nutraceutical options alongside Biolab's pharmaceuticals.
- Cosmeceuticals (เวชสำอาง) High-quality dermatological and skincare products that combine pharmaceutical and cosmetic benefits. Targeted at consumers seeking clinically positioned skincare products distributed through healthcare and beauty channels.
- R&D (Research and Development) Services Research and development of new pharmaceutical formulations to meet diverse healthcare needs. Available to pharmaceutical companies and healthcare brands seeking co-development of new products, leveraging Biolab's experienced R&D team and laboratory capabilities.
- OEM/ODM Manufacturing Services Original Equipment Manufacturing and Original Design Manufacturing services meeting international production standards (PIC/S GMP, EU GMP). Available to domestic and international pharmaceutical companies requiring certified production capacity, currently serving partners exporting to 20+ countries.
- Product Registration Services Consulting and execution services for product registration and regulatory compliance. Provided to pharmaceutical companies navigating Thai FDA and international regulatory submissions alongside Biolab's manufacturing capabilities.
- Laboratory Testing Services ISO/IEC 17025 accredited laboratory testing services to ensure product quality and safety standards. Available to pharmaceutical manufacturers and partners requiring independent testing and quality verification.
Companies that use Biolab
Customer profileSegments3 records
Ideal customer profiles3 records
Biolab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Biolab partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
Biolab competitors and assessment
Company assessmentDirect peers
- Greater Pharma: Thailand-based pharmaceutical manufacturer producing generic drugs, supplements, and consumer health products. Direct in-market competitor with overlapping product categories and similar distribution approach.
- Government Pharmaceutical Organization (GPO Thailand): Thailand's state-owned pharmaceutical manufacturer producing generics and essential medicines. While state-owned, it shares the same Thai regulatory environment, market, and bulk generics manufacturing model as Biolab.
- Yung Shin Pharmaceutical: Taiwan-based generic pharmaceutical manufacturer with PIC/S GMP certifications and OEM/ODM capabilities exporting across Asia. Highly comparable to Biolab in scale, generic-formulation focus, and Southeast/East Asian export orientation.
- Olic (Thailand): Thai pharmaceutical manufacturer producing generic drugs, supplements, and consumer health products for domestic and export markets. Comparable Thai-based generic manufacturer with similar product breadth and customer segments.
- Recipharm: European CDMO offering contract development and manufacturing services for generics and specialty pharma. Comparable OEM/ODM contract manufacturing model with international regulatory certifications.
- Siam Pharmaceutical: Thai pharmaceutical company focused on generic drug manufacturing with domestic and regional exports. Comparable Thai OEM/ODM generics manufacturer.
Broad incumbents
- Aurobindo Pharma: Large Indian global generic manufacturer with extensive OEM/ODM and contract manufacturing capabilities. Competitor in the same end markets though at a far larger scale, useful for benchmarking pricing and international reach.
Regional players
- Dexa Medica: Indonesia's largest domestic pharmaceutical manufacturer, focused on generic and branded generics with growing ASEAN distribution. Comparable as a Southeast Asian generic pharma manufacturer with similar OEM/ODM partnerships.
Emerging players
- Strides Pharma: India-based global pharmaceutical manufacturer focused on generics and CDMO services with regulated market approvals. Directly comparable contract manufacturer competing for similar OEM/ODM contracts.
Others
- Eurofins Scientific: Global laboratory testing services provider with ISO/IEC 17025-compliant facilities. Comparable to Biolab's in-house laboratory testing service line and to the company's ISO/IEC 17025 accreditation positioning.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Biolab social profiles
Digital presenceBiolab compliance and trust
Trust signalCompliance8 records
Biolab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biolab leadership team
Management profileNumber of profiles
Biolab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biolab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biolab
What does Biolab do?
Biolab Co., Ltd. manufactures generic pharmaceutical products, dietary supplements (Pharmafood), and cosmeceuticals, and provides OEM/ODM contract manufacturing, R&D of new formulations, product registration consulting, and laboratory testing services. The company produces over 100 products across 13 therapeutic categories (Gastrointestinal, Musculo-Skeletal, Endocrine & Metabolic, Dermatologicals, CNS, Allergy & Immune, Anti-Infectives, Respiratory, Contraceptives, Cardiovascular, Hormones, Calcium & Mineral, and Detoxifying Agents) and exports to 20+ countries.
Is Biolab a public or private company?
Biolab is a private company. It is classified as unknown and is currently operating.
When was Biolab founded?
Biolab was founded in 1980. It employs 11 to 50 people.
Where is Biolab based?
Biolab is headquartered in Muang Samut Prakan, Thailand, in the Asia region.
How does Biolab make money?
Four revenue lines are on record. Pharmaceutical Manufacturing (OEM/ODM) is the primary driver. The others are own Brand Pharmaceuticals, product Registration Consulting and laboratory Testing Services.
Who are Biolab's main competitors?
Direct peers on record are Greater Pharma, Government Pharmaceutical Organization (GPO Thailand), Yung Shin Pharmaceutical, Olic (Thailand), Recipharm and Siam Pharmaceutical. Aurobindo Pharma is listed as a broad incumbent. Dexa Medica is listed as a regional player. Strides Pharma is listed as an emerging player. Eurofins Scientific is listed as an others.
Does Biolab have an API?
No public API is recorded for Biolab.
What industry is Biolab in?
Biolab's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines). Its NAICS code is 3254 and its SIC code is 2834.